{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:40:12Z","timestamp":1790185212134,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.rmed.2024.107585","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T07:19:52Z","timestamp":1710141592000},"page":"107585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4260-2042","authenticated-orcid":false,"given":"Mathilde","family":"Steger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Canuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Enache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-203X","authenticated-orcid":false,"given":"Thibaut","family":"Goetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aissam","family":"Labani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1625-5215","authenticated-orcid":false,"given":"Guillaume","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":false,"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-8582","authenticated-orcid":false,"given":"Marianne","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2024.107585_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.healun.2011.11.020","article-title":"Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease","volume":"31","author":"Andersen","year":"2012","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.rmed.2024.107585_bib2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"Thabut","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107585_bib3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/COPD.S359873","article-title":"The incidence and prevalence of pulmonary hypertension in the COPD population: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2024.107585_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00944-2021","article-title":"Elevated pulmonary vascular resistance predicts mortality in COPD patients","volume":"58","author":"Zeder","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1203830","article-title":"Pulmonary arterial enlargement and acute exacerbations of COPD","volume":"367","author":"Wells","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107585_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1378\/chest.11-2798","article-title":"Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension","volume":"142","author":"Boerrigter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107585_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"\u201cNatural history\u201d of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease","volume":"164","author":"Kessler","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/ajrccm.159.1.9803117","article-title":"Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease","volume":"159","author":"Kessler","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.107.5.1193","article-title":"Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure","volume":"107","author":"Oswald-Mammosser","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107585_bib12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2024.107585_bib13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","article-title":"Pulmonary vascular involvement in chronic obstructive pulmonary disease. Is there a pulmonary vascular phenotype?","volume":"198","author":"Kovacs","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.chest.2022.01.031","article-title":"Severe pulmonary hypertension in COPD: impact on survival and diagnostic approach","volume":"162","author":"Kovacs","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107585_bib15","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"2022","author":"Humbert","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118001","article-title":"Efficacy and safety of Sildenafil treatment in pulmonary hypertension caused by chronic obstructive pulmonary disease: a meta-analysis","volume":"257","author":"Hao","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.rmed.2024.107585_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/690017","article-title":"Chronic use of PAH-specific therapy in world Health organization group III pulmonary hypertension: a systematic review and meta-analysis","volume":"7","author":"Prins","year":"2017","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.rmed.2024.107585_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/15412555.2011.651180","article-title":"Sildenafil for chronic obstructive pulmonary disease: a randomized crossover trial","volume":"9","author":"Lederer","year":"2012","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2024.107585_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1183\/09031936.00011308","article-title":"A randomised, controlled trial of bosentan in severe COPD","volume":"32","author":"Stolz","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107585_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/MCP.0000000000000890","article-title":"Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide","volume":"28","author":"Garc\u00eda","year":"2022","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2024.107585_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2024.107585_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S2213-2600(22)00097-2","article-title":"Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis","volume":"10","author":"Hoeper","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2024.107585_bib25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2021.04.021","article-title":"Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a prospective French multicenter cohort","volume":"40","author":"Dauriat","year":"2021","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.rmed.2024.107585_bib26","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2016.04.010","article-title":"Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial","volume":"36","author":"Vitulo","year":"2017","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.rmed.2024.107585_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0043-1770121","article-title":"Management of pulmonary hypertension associated with chronic lung disease","volume":"44","author":"Blanco","year":"2023","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib29","series-title":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2023"},{"key":"10.1016\/j.rmed.2024.107585_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201402-0269PP","article-title":"Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings","volume":"190","author":"Kovacs","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chest.2021.02.012","article-title":"Pulmonary hypertension in patients with COPD: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"160","author":"Vizza","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107585_bib32","first-page":"9","article-title":"Pulmonary arterial hypertension-specific drug therapy in COPD patients with severe pulmonary hypertension and mild-to-moderate airflow limitation","volume":"91","author":"Calcaianu","year":"2016","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"10.1016\/j.rmed.2024.107585_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02897-2021","article-title":"Severe pulmonary hypertension associated with COPD: long-term results of a prospective French multicentre cohort","volume":"60","author":"Dauriat","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib34","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.healun.2020.09.011","article-title":"Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry","volume":"39","author":"Hoeper","year":"2020","journal-title":"J. Heart Lung Transplant. Off. Publ. Int. Soc. Heart Transplant."},{"key":"10.1016\/j.rmed.2024.107585_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.2107027","article-title":"Hemodynamic characterization of patients with severe emphysema","volume":"166","author":"Scharf","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiology.211.2.r99ma52541","article-title":"Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results","volume":"211","author":"Park","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.rmed.2024.107585_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1753465808103499","article-title":"Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease","volume":"3","author":"Valerio","year":"2009","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2024.107585_bib38","first-page":"81","article-title":"Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial","volume":"53","author":"Rao","year":"2011","journal-title":"Indian J. Chest Dis. Allied Sci."},{"key":"10.1016\/j.rmed.2024.107585_bib39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107585_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chest.2019.02.333","article-title":"Pulmonary arterial histologic lesions in patients with COPD with severe pulmonary hypertension","volume":"156","author":"Bunel","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107585_bib41","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1183\/09031936.00184412","article-title":"Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses","volume":"42","author":"Trip","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107585_bib42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1164\/rccm.202204-0671PP","article-title":"Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision","volume":"206","author":"Celli","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107585_bib43","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","article-title":"Clinical significance of symptoms in smokers with preserved pulmonary function","volume":"374","author":"Woodruff","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:40:23Z","timestamp":1760618423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":43,"alternative-id":["S0954611124000593"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107585","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107585"}}